Clinical Trials Browser

Phase 1 × Completed × relmacabtagene autoleucel × Clear all

NCT04812691 2023-11-22

CD19-targeted CAR T Cells （JWCAR029） for Primary Refractory Diffuse Large B Cell Lymphoma

Phase 1 Completed

Lymphoma, Large B-Cell, Diffuse